Drug Discovery and Development

Drug discovery is a process which is intended to identify a small synthetic molecule or a large biomolecule for comprehensive evaluation as a potential drug candidate. Broadly, the modern drug discovery process includes identification of disease to be treated and its unmet medical need, selection of a druggable molecular target and its validation, in vitro assay development followed by high throughput screening of compound libraries against the target to identify hits, and hit optimization to generate lead compounds that exhibit adequate potency and selectivity towards the biological target in vitro and which demonstrate efficacy in animal models of disease. Subsequently, the lead compounds are further optimized to improve their efficacy and pharmacokinetics before they advance towards drug development.

Drug development process can be segregated into preclinical and clinical development stages. In preclinical development, toxicological and safety pharmacology studies of the candidate are conducted in order to establish the maximum safe concentrations in animals and determine the adverse effect potential of the drug-in-development. Additionally, studies are conducted to finalize cost-effective processes required for manufacturing the candidate drug as well as deciding on its best formulation. If the candidate exhibits sufficient efficacy and safety in preclinical evaluation, permission is sought from drug regulatory agencies to initiate its clinical development wherein the safety and efficacy of the drug candidate is assessed in pilot and pivotal studies.

 

  • Computational approaches in drug discovery and precision medicine
  • Phosphonate chemistry in drug design and development
  • In silico methods for drug design and discovery
  • Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
  • Anti-Tubercular drugs
  • Computational drug discovery for targeting of protein-protein interfaces
  • Multi-target-directed ligands (MTDL) in drug discovery: from design to pharmacological evaluation

Related Conference of Drug Discovery and Development

April 24-25, 2025

6th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
April 29-30, 2025

11th International Conference on Epilepsy & Treatment

Barcelona, Spain
May 12-13, 2025

39th European Neurology Congress

London, UK
July 17-18, 2025

31st Annual Summit on Neuroscience & Neurological Disorders

Amsterdam, Netherlands
July 23-24, 2025

15th Global Alzheimers Summit

Paris, France
July 28-29, 2025

35th World Congress on Neurology and Neuroscience

Paris, France
August 25-26, 2025

20th Annual Congress on Neuroscience

Aix-en-Provence, France
September 04-05, 2025

10th Annual Neurologists and Neurosurgeons Meet

Vancouver, Canada
September 25-26, 2025

12th Annual congress on Stroke and Neurological Disorders

Zurich, Switzerland
October 20-21, 2025

7th World Brain Congress

Osaka, Japan
October 23-24, 2025

8th Global Congress on Spine and Spinal Disorders

London, UK
October 29-30, 2025

5th Annual Dementia Congress

Amsterdam, Netherlands
November 13-14, 2025

32nd Cognitive Neuroscience Congress

Bali, Indonesia
December 04-05, 2025

17th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands

Drug Discovery and Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in